Physician profile
Manish Gupta Kumar
NPI 1033198395
$1,886.50
in general payments reported to CMS, 2019-2025
19 companies · $99.99 in 2025
The $99.99 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,130 · 2020: $64.95 · 2021: $127 · 2022: $162 · 2023: $172 · 2024: $131 · 2025: $99.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $344 · Food and Beverage: $58.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $343.74 |
| Food and Beverage | $58.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $470.99 | 2019-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $253.58 | 2019-2020 | |
| Abbvie INC. | $210.00 | 2019 | |
| Abbott Laboratories | $149.64 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $113.91 | 2021-2023 | Breztri |
| Celgene Corporation | $112.64 | 2019 | |
| Pfizer INC. | $83.27 | 2020-2024 | |
| Genzyme Corporation | $82.11 | 2019 | |
| Novo Nordisk INC | $78.25 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $76.46 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $44.00 | 2019 | |
| Genentech, INC. | $39.95 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.48 | 2021 | |
| Amgen INC. | $31.33 | 2019 | |
| Dermira, INC. | $23.66 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $21.86 | 2019 | |
| Prugen, INC. Pharmaceuticals | $21.37 | 2019 | |
| Ucb, INC. | $21.25 | 2019 | |
| Galderma Laboratories, L.P. | $19.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manish Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.